Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.32326 | 12 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.29397 | 12 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.2978 | 12 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.23826 | 11 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.26232 | 12 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.35131 | 12 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.31348 | 12 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.27619 | 12 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.25682 | 11 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.28153 | 12 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.27957 | 12 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.27866 | 12 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.2869 | 12 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.28441 | 12 |